- Este evento ha pasado.
Conference Call and Webcast to discuss the License and Commercialization agreement with Chugai Pharmaceuticals for Lurbinectedin in Japan
4 enero, 2017 @ 2:00 - 16:00
Investors who wish to participate in the conference call may do so by dialing 877-407-3102 for U.S. and Canadian callers or 201-493-6790 for international callers and 900 834 236 for Spain. Those interested in listening to the conference call via the internet may do so by visiting: